Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes

  1. Dietrich, F.
  2. Barcenilla, H.
  3. Tavira, B.
  4. Wahlberg, J.
  5. Achenbach, P.
  6. Ludvigsson, J.
  7. Casas, R.
Journal:
Diabetes/Metabolism Research and Reviews

ISSN: 1520-7560,  1520-7552

Year of publication: 2022

Volume: 38

Issue: 3

Type: Article

DOI: 10.1002/DMRR.3500 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus